Locus Fermentation Solutions (Locus FS) expanded its operational footprint by 100,000 ft2. The expansion includes two biomanufacturing facilities in Solon, OH which, according to the company, enable Locus to increase its biological production capacity by three times and support global decarbonization efforts across key sectors, said Andrew (Andy) Lefkowitz, chairman, and CEO.
“Through our expanded facilities, Locus FS is strategically positioned to meet the growing demand for sustainable biological innovations and carbon-neutral biomanufacturing,” he continued.
With the expanded production capacity, Locus FS can cater to the needs of its blue-chip distribution partners such as Dow, adds Lefkowitz, noting that both campuses feature low-carbon technologies that reduce environmental impact and provide significant cost and energy savings.
“Locus FS’ patented fermentation allows rapid scaling to meet demand within nine months, versus years,” claims Scott Weber, vice president of production at Locus FS. “This expansion is just phase one; but our new facilities have the potential capacity to reach 2.5 million kilograms of biosurfactant production annually in the future.”
The Biden administration’s Executive Order on Biotechnology and Biomanufacturing Innovation highlights the need for increased domestic biological production. Locus FS is a key solution to strengthen national biomanufacturing capacity, addressing the need for expanded capabilities.
